The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Study Finds Chronic Opioid Use Doubled in Rheumatoid Arthritis Patients

Study Finds Chronic Opioid Use Doubled in Rheumatoid Arthritis Patients

September 17, 2019 • By Mary Beth Nierengarten

  • Tweet
  • Email
Print-Friendly Version / Save PDF
PureRadiancePhoto / shutterstock.com

PureRadiancePhoto / shutterstock.com

The prevalence of chronic opioid use among patients with rheumatoid arthritis (RA) doubled between 2002 and 2015, especially among patients with severe pain or on antidepressants, according to a new study.1

You Might Also Like
  • Chronic Opioid Use in Rheumatoid Arthritis: Prevalence & Predictors
  • Medical Cannabis Helps Chronic Pain Patients Cut Opioid Use
  • Study Finds Eating Fresh Fish May Ease Rheumatoid Arthritis Symptoms
Explore This Issue
September 2019
Also By This Author
  • Study Finds Pedometers Reduce Fatigue in RA Patients

The study adds to prior data reporting trends in chronic opioid use in RA patients.2,3 Severe pain was the strongest predictor for use of chronic opioids, with hazard ratio of 2.53 (95% confidence interval [CI], 2.19–2.92).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“It was interesting that this relationship was independent of RA disease activity. In other words, the association between pain and chronic opioid use wasn’t solely because they had uncontrolled inflammation from the RA; they may have had pain due to other causes as well,” says the study’s lead author, Yvonne C. Lee, MD, MMSc, an associate professor in the Division of Rheumatology at Northwestern Medicine, Chicago.

This observation points to the need for clinicians to accurately identify the cause of patients’ pain and treatment with disease-modifying anti-rheumatic drugs, she says.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The Study

In the study, Dr. Lee and colleagues used data from 33,739 RA patients identified through the Corrona registry from 2002–15. Since 2002, the Corrona registry has enrolled >42,000 persons with RA through both academic and community rheumatologists.

To calculate the annual prevalence of chronic opioid use in this cohort, the investigators defined chronic opioid use as any opioid use reported by patients during two or more consecutive study visits.

Dr. Lee

Dr. Lee

The study found chronic opioid use more than doubled from 2002–15 among these patients, from 7.4% in 2002 to 16.9% in 2015. An even greater increase was found among RA patients who contributed two or more data points in a given year, with a prevalence of 14.1% in 2002 rising to 31.3% in 2015.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Lee and colleagues also looked at potential predictors of chronic opioid use in 26,288 patients who were not taking opioids at baseline. They looked at both patient characteristics (e.g., age, ethnicity, sex) and RA disease characteristics (e.g., seropositivity, disease duration, disease activity), along with medication use.

The Clinical Disease Activity Index score was used to measure disease activity, disability was assessed using the Health Assessment Questionnaire, and pain intensity was assessed using a scale of 0–100 based on the question, “How much pain have you had because of your arthritis in the past week?”1

Following severe pain, the second strongest predictor was antidepressant use, with a hazard ratio of 1.79 (95% CI, 1.64-1.92). Less strong, but still predictive of chronic opioid use, was high disease activity, with a hazard ratio of 1.55 (95% CI, 1.30–1.84), and high level of disability, with a hazard ratio of 1.45 (95% CI, 1.27–1.65).

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Research Reviews, Rheumatoid Arthritis Tagged With: opioid crisis, Pain Management, RA Resource CenterIssue: September 2019

You Might Also Like:
  • Chronic Opioid Use in Rheumatoid Arthritis: Prevalence & Predictors
  • Medical Cannabis Helps Chronic Pain Patients Cut Opioid Use
  • Study Finds Eating Fresh Fish May Ease Rheumatoid Arthritis Symptoms
  • Opioid Use in U.S. RA Patients

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)